Echocardiography Predictors and Prognostic Value of Pulmonary Artery Systolic Pressure in Chronic Organic Mitral Regurgitation
Overview
Authors
Affiliations
Objective: To evaluate the predictors of pulmonary artery systolic pressure (PASP) in organic mitral regurgitation (MR) and its prognostic value after surgery.
Design: Prospective observational study, conducted from 1998 to 2006.
Setting: Echocardiography and cardiac surgery departments, University Hospital.
Patients: Echocardiography was carried out in 256 patients (63+/-12 years, 170 male) with organic MR (degenerative aetiology: 91%) referred for surgery.
Main Outcome Measures: Echocardiography predictors of PASP. Postoperative end points were overall mortality and cardiovascular mortality.
Results: Baseline PASP was 45+/-14 mmHg, ranging from 25 to 105 mmHg. PASP was > or = 50 mmHg in 82 patients (32%). Left atrial volume (p=0.003), mitral deceleration time (p<0.0001) and mitral medial E/E' (p<0.0001) were independent predictors of PASP, whereas left ventricular size and systolic function were not predictors. Mitral valve repair was performed in 194 patients (76%) and mitral valve replacement in 62 (24%). In a Cox model mitral valve repair (HR=0.41 (95% CI 0.20 to 0.85), p=0.016) and PASP (HR=1.43 (95% CI 1.09 to 1.88) per 10 mmHg increment, p=0.011) were independent predictors of overall mortality, even after adjustment for known predictors. PASP (HR=1.49 (95% CI 1.03 to 2.16) per 10 mmHg increment, p=0.033) was also an independent predictor of cardiac mortality. Eight-year survival after surgery was 58.6% and 86.6% in patients with baseline PASP > or = 50 mmHg or <50 mmHg, respectively (p<0.0001).
Conclusions: In organic MR, mitral deceleration time, mitral E/E' and left atrial volume correlate with PASP. Pulmonary artery systolic pressure > or = 50 mmHg is an independent predictor of overall and cardiovascular mortality after surgery in organic MR.
Yang Y, Fang L, Wu W, Li H, He L, Liu M Rev Cardiovasc Med. 2024; 25(11):414.
PMID: 39618881 PMC: 11607497. DOI: 10.31083/j.rcm2511414.
Marsac P, Wallet T, Redheuil A, Gueda Moussa M, Lamy J, Nguyen V Sci Rep. 2024; 14(1):21429.
PMID: 39271732 PMC: 11399337. DOI: 10.1038/s41598-024-71563-4.
Exercise Pulmonary Hypertension in Heart Valve Disease.
Schiavo A, Bellino M, Moreo A, Casadei F, Carbone A, Rega S Rev Cardiovasc Med. 2024; 25(4):131.
PMID: 39076551 PMC: 11264010. DOI: 10.31083/j.rcm2504131.
Haddad A, Mohamed A, Arends S, Ishak B, Tsarenko O, Balaj I J Thorac Dis. 2024; 16(4):2259-2273.
PMID: 38738229 PMC: 11087627. DOI: 10.21037/jtd-23-1727.
van de Veerdonk M, Roosma L, Trip P, Gopalan D, Vonk Noordegraaf A, Dorfmuller P Eur Respir Rev. 2024; 33(171).
PMID: 38417969 PMC: 10900069. DOI: 10.1183/16000617.0144-2023.